BJ HEALTH (02389) announced its interim results, reporting a shareholder loss of HKD 31.797 million, an increase of 8.76% year-on-year.
Beijing Health (02389) announced its interim results for the six months ending June 30, 2026, reporting a revenue of HKD 30.279 million, a decrease of 60.46% year-on-year; the loss attributable to the owners of the parent company was HKD 31.797 million, an increase of 8.76% year-on-year; the loss per share was HKD 0.052.
BJ HEALTH (02389) announced its interim results for the six months ending June 30, 2026, reporting revenue of HKD 30.279 million, a year-on-year decrease of 60.46%; the loss attributable to the parent companys owners was HKD 31.797 million, an increase of 8.76% compared to the previous year; and the loss per share was HKD 0.052.
The announcement stated that the decline in operating revenue was mainly due to a significant reduction in sales revenue from healthcare and wellness products.
Related Articles

MEGA GENOMICS (06667) released its interim results, with revenue reaching 192 million yuan, a significant year-on-year increase of 136.8%.

ZALL SMARTCOM (02098) announced its interim results, reporting a loss attributable to equity shareholders of approximately 1.149 billion yuan, compared to a profit in the same period last year.

WORLD-LINK LOG (06083) announced its interim results, with a profit attributable to shareholders of HK$6.261 million, a decrease of 10.62% year-on-year.
MEGA GENOMICS (06667) released its interim results, with revenue reaching 192 million yuan, a significant year-on-year increase of 136.8%.

ZALL SMARTCOM (02098) announced its interim results, reporting a loss attributable to equity shareholders of approximately 1.149 billion yuan, compared to a profit in the same period last year.

WORLD-LINK LOG (06083) announced its interim results, with a profit attributable to shareholders of HK$6.261 million, a decrease of 10.62% year-on-year.

RECOMMEND





